Janku Filip — SEC Form 4 filings
SEC reporting owner CIK 1862930. 7 Form 4 filings on record with FilingPulse; latest filed 2026-07-01.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-09-13 to 2026-07-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 5 filings — 65,596 shares, $1,379,397 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 30,000 shares @ $21.42 ($642,681) in Monte Rosa Therapeutics, Inc., filed 2026-06-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | 7 | — | 6 legs · 65,596 sh · $1,379,397 | 13 |
Form 4 filings — Janku Filip
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-01 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Option exercise (M): 5,407 @ $13.41 · Sale (S): 5,407 @ $24.50 · Option exercise (M): 5,407 (derivative) @ $0 | EDGAR |
| 2026-06-30 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Option exercise (M): 6,000 @ $7.56 · Sale (S): 6,000 @ $22.95 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Option exercise (M): 6,000 @ $7.56 · Sale (S): 11,845 @ $20.22 · Option exercise (M): 30,000 @ $7.56 · Sale (S): 30,000 @ $21.42 · Option exercise (M): 6,000 (derivative) @ $0 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Sale (S): 9,189 @ $19.50 | EDGAR |
| 2026-01-05 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/award (A): 31,000 · Sale (S): 3,155 @ $15.17 · Grant/award (A): 139,000 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/award (A): 36,000 · Grant/award (A): 161,000 (derivative) @ $0 | EDGAR |
| 2024-09-13 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1862930 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →